Background {#Sec1}
==========

Weaning accounts for approximately 40% of the time spent on mechanical ventilation \[[@CR1], [@CR2]\]. Compared with nonprotocolized care, randomized controlled trials (RCTs) and a systematic review indicate that weaning protocols reduce the duration of mechanical ventilation, weaning time, and intensive care unit (ICU) length of stay (LOS) \[[@CR3], [@CR4]\]. After identification, patients may undergo a spontaneous breathing trial (SBT) to assess their ability to breathe spontaneously with minimal or no support.

Clinicians conduct SBTs to facilitate decision-making regarding timely extubation and to minimize patients' exposure to invasive ventilation. In making decisions, clinicians 'trade off' the risks associated with delayed extubation and those associated with a premature failed attempt at extubation. Several techniques are commonly used to conduct SBTs, including pressure support (PS) with or without positive end-expiratory pressure (PEEP), continuous positive airway pressure (CPAP), automatic tube compensation (ATC), and the T-piece. Whereas some SBT techniques deliver pressure during inspiration to overcome endotracheal tube resistance (e.g., PS, ATC), other techniques aim to improve respiratory mechanics or cardiac function (e.g., CPAP) and may overestimate patients' ability to breathe autonomously after extubation \[[@CR5]\]. Conversely, the T-piece provides no support, is perceived to increase work of breathing (WOB), and may underestimate patients' ability to breathe spontaneously after extubation \[[@CR5]\]. The most recent American College of Chest Physicians/American Thoracic Society Clinical Practice Guidelines \[[@CR6]\] support that an SBT is the major diagnostic test to determine whether patients can be extubated but give only a conditional (weak) recommendation that PS SBTs should be used as the initial SBT, based on limited data (three or four included RCTs).

A Cochrane review of nine trials compared PS and T-piece 'weaning' in adults and found nonsignificant differences between techniques on weaning success, pneumonia, reintubation, ICU mortality, and LOS. In a subgroup analysis (four trials, *n* = 940) the authors noted that patients were significantly more likely to pass a PS SBT vs a T-piece SBT (risk ratio (RR) 1.09, 95% confidence interval (CI) 1.02--1.17) \[[@CR7]\]. This review did not directly compare alternative SBT techniques and was limited to full publications of adults. At present, no SBT technique has been shown to be superior to another.

We sought to summarize the RCT evidence directly comparing all alternative SBT techniques involving critically ill adults and children on initial SBT success, extubation success, reintubation rate (primary outcomes), and other important outcomes.

Methods {#Sec2}
=======

Data sources {#Sec3}
------------

We searched MEDLINE (1966--February 2017), EMBASE (1980--February 2017), the Cochrane Central Register of Controlled Trials (CENTRAL, February 2017), CINAHL (1982--February 2017), evidence-based medicine reviews, and Ovid Health Star (1999--February 2017) to identify potentially eligible trials using database-specific search strategies without language restrictions. We used the optimally sensitive search strategies of The Cochrane Collaboration for MEDLINE and EMBASE \[[@CR8]--[@CR10]\]. Two authors (KEAB, JOF) independently screened citation titles and abstracts and evaluated full-text versions of potentially relevant trials. Five authors hand-searched conference proceedings of five scientific meetings from 1990--2016: European Society of Intensive Care Medicine, American College of Chest Physicians (except 1999--2002, unavailable), American Thoracic Society, International Symposium of Intensive Care and Emergency Medicine, and Society of Critical Care Medicine (including 2017 for the latter). Ethics approval was not required.

Study selection {#Sec4}
---------------

We included randomized or quasi-randomized trials comparing two or more SBT techniques in critically ill adults or children reporting at least one of initial SBT or extubation outcome (success or failure), reintubation, time to extubation or successful extubation, time to first successful SBT, mortality, ventilator-associated pneumonia (VAP), total duration of ventilation, ICU or hospital LOS, postextubation use of noninvasive ventilation (NIV), or adverse events using authors' definitions. We excluded trials that evaluated: neonatal or tracheostomized patients; SBTs as part of a weaning strategy; automated SBTs (e.g., SmartCare™, Intellivent®); NIV vs continued invasive ventilation; and SBT conduct vs no SBT. Two authors (KEAB, JOF) independently selected trials meeting inclusion criteria, and another author (LJB) adjudicated differences.

Data extraction and quality assessment {#Sec5}
--------------------------------------

Two unblinded authors (KEAB, JOF) abstracted data regarding the study risk of bias (RoB) (randomization, allocation concealment, blinded outcomes assessment, completeness of follow-up, selective outcomes reporting, stopping early for benefit) and recorded outcomes, using authors' definitions for reported outcomes, on a standardized form \[[@CR11]\]. We evaluated RoB (yes, unclear, no) for each domain. Disagreements were resolved by consensus and arbitration with a third author (LJB).

Data synthesis {#Sec6}
--------------

We pooled data across studies using random effects models. We derived summary estimates of RR and mean difference (MD) with 95% CI for binary and continuous outcomes, respectively, using Review Manager 5.3 (Cochrane Collaboration, Oxford, UK) \[[@CR12]\]. We pooled 'initial SBT success' in trials that conducted more than one SBT. We evaluated statistical heterogeneity for each outcome using the *I* ^2^ measure with thresholds of 0--40% (might not be important), 30--60% (moderate), 50--90% (substantial), and [\>]{.ul}75% (considerable) \[[@CR13], [@CR14]\]. We summarized trials based on the techniques compared (e.g., T-piece vs other) (Additional file [1](#MOESM1){ref-type="media"}).

We planned subgroup analyses to compare the effects of different techniques on primary outcomes in perioperative vs nonperioperative trials and based on: duration of ventilation at randomization (nonperioperative trials); the support provided during SBTs; the type of lung disease; and methodologic quality (low/moderate vs high RoB). We assessed for subgroup differences using the chi-square test \[[@CR15]\].

We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to assess the quality of the body of evidence associated with the primary outcomes and significant secondary outcomes \[[@CR16]\]. We assessed for publication bias when at least 10 trials were identified \[[@CR17]\]. A written protocol was used to guide the review process.

Results {#Sec7}
=======

Trial identification {#Sec8}
--------------------

We identified 4218 unique citations. We assessed 187 articles for eligibility and excluded 156 studies (Fig. [1](#Fig1){ref-type="fig"}). Thirty-one trials \[[@CR18]--[@CR48]\] reporting on 3541 patients met our inclusion criteria including five trials comparing three SBT techniques \[[@CR23], [@CR24], [@CR29], [@CR30], [@CR48]\]. Two trials \[[@CR38], [@CR46]\] appeared to be published, at least in part, in duplicate \[[@CR49], [@CR50]\]. The most common comparisons were T-piece vs PS (13 trials), T-piece vs CPAP (nine trials), PS vs ATC (three trials), and CPAP vs ATC (three trials). Four trials \[[@CR21], [@CR34], [@CR38], [@CR40]\] were not published in English. Six trials \[[@CR25], [@CR27], [@CR33], [@CR36], [@CR45], [@CR47]\] were published as abstracts, of which two \[[@CR36], [@CR47]\] provided partial or full-text manuscripts. Nine trials \[[@CR19]--[@CR21], [@CR23]--[@CR25], [@CR44], [@CR45], [@CR47]\] evaluated perioperative populations (six cardiac surgical \[[@CR19]--[@CR21], [@CR24], [@CR25], [@CR44]\] and three other surgical \[[@CR23], [@CR45], [@CR47]\]). Three trials \[[@CR28], [@CR43], [@CR46]\] evaluated pediatric patients.Fig. 1Identification of trials included in the meta-analysis. *SBT* spontaneous breathing trial, *PEEP* positive end-expiratory pressure

Quality assessment {#Sec9}
------------------

We judged randomization and allocation concealment to be at low RoB in 16 (52%) trials and 17 (55%) trials, respectively. One quasi-randomized trial allocated patients based on even or odd days \[[@CR34]\]. No trial evaluated outcomes in a blinded manner. We judged 15 (48%) trials to have complete outcomes reporting. Eighteen (58%) trials conducted an intention-to-treat analysis and 26 (84%) trials did not stop early for benefit. Overall trial quality was moderate (Additional file [2](#MOESM2){ref-type="media"}: Figure S1).

Primary outcomes {#Sec10}
----------------

### Initial SBT success {#Sec11}

Seventeen T-piece, 12 CPAP, eight ATC, and 13 PS trials directly compared one SBT technique with another and reported initial SBT success (Table [1](#Tab1){ref-type="table"}). Compared with T-piece SBTs, moderate-quality evidence supports that patients undergoing PS SBTs were not more likely to pass an SBT (RR 1.00, 95% CI 0.89--1.11; *p* = 1.0; nine trials, *n* = 1901) with considerable heterogeneity (*I* ^2^ = 77%) (Table [2](#Tab2){ref-type="table"}, Fig. [2](#Fig2){ref-type="fig"}, Additional file [3](#MOESM3){ref-type="media"}: Figure S2).Table 1Characteristics of included trialsAuthor and yearInterventionsCountryPublication TypePopulationDuration of ventilation at inclusionFeeley 1975 \[[@CR18]\] (*n* = 25)T-piece/PEEP 5 cmH~2~O vs T-pieceUSAFullAdultNot reportedHastings 1980 \[[@CR19]\] (*n* = 18)IMV/CPAP 5 cmH~2~O vs T-piece/CPAP 5 cmH~2~OUSAFullAdultPerioperativePrakash 1982 \[[@CR20]\] (*n* = 28)IMV vs SVT (on ventilator)The NetherlandsFullAdultPerioperativeKoller 1983 \[[@CR21]\] (*n* = 45)CPAP 10 cmH~2~O vs T-piece/ZEEPAustriaFullAdultPerioperativeJones 1991 \[[@CR22]\] (*n* = 106)CPAP 5 cmH~2~O vs T-piece/ZEEPUSAFullAdultNot reportedAbalos 1992 \[[@CR23]\] (*n* = 62)SIMV vs CPAP 4 cmH~2~O vs T-pieceUSAFullAdultPerioperativeBailey 1995 \[[@CR24]\] (*n* = 82)T-piece^a^ vs CPAP 5 cmH~2~O vs CPAP 10 cmH~2~OEnglandFullAdultPerioperativeSchinco 1995 \[[@CR25]\] (*n* = 30)PS 5 cmH~2~O/CPAP 5 cmH~2~O vs CPAP 5 cmH~2~OUSAAbstractAdultPerioperativeEsteban 1997 \[[@CR26]\] (*n* = 484)T-piece vs PS 7 cmH~2~OSpain and South AmericaFullAdult\>48 hoursHolanda 2000 \[[@CR27]\] (*n* = 35)T-piece vs PSBrazilAbstractAdult\>48 hoursFarias 2001 \[[@CR28]\] (*n* = 257)T-piece vs PS 10 cmH~2~O ± PEEP 5 cmH~2~OArgentinaFullPediatric\>48 hoursHaberthur 2002 \[[@CR29]\] (*n* = 90)PS 5 cmH~2~O/PEEP 5 cmH~2~O vs ATC/PEEP 5 cmH~2~O vs T-pieceSwitzerlandFullAdult\>24 hoursKoksal 2004 \[[@CR30]\] (*n* = 60)PS [\<]{.ul} 10 cmH~2~O/PEEP [\<]{.ul} 5 cmH~2~O vs CPAP [\<]{.ul} 5 cmH~2~O vs T-pieceTurkeyFullAdult\>48 hoursMatic 2004 \[[@CR31]\] (*n* = 260)T-piece vs PS 8 cmH~2~OCroatiaFullAdult\>48 hoursCohen 2006 \[[@CR32]\] (*n* = 99)ATC^b^/CPAP 5 cmH~2~O vs CPAP 5 cmH~2~OIsraelFullAdult\>24 hoursLiang 2006 \[[@CR33]\] (*n* = 97)ATC vs T-pieceTaiwanAbstractAdult\>4 daysColombo 2007 \[[@CR34]\] (*n* = 120)T-piece vs PS 7 cmH~2~O/PEEP 5 cmH~2~OBrazilFullAdult\>48 hoursMatic 2007 \[[@CR35]\] (*n* = 136)T-piece vs PS (not specified)CroatiaFullAdult\>24 hoursFayed 2008 \[[@CR36]\] (*n* = 30)ATC^b^/CPAP 5 cmH~2~O vs CPAP 5 cmH~2~OEgyptAbstractAdult\>24 hoursCohen 2009 \[[@CR37]\] (*n* = 180)ATC^b^/CPAP 5 cmH~2~O vs PS 7 cmH~2~O/CPAP 5 cmH~2~OIsraelFullAdult\>24 hoursZhang 2009 \[[@CR38]\] (*n* = 208)T-piece vs PS 5 cmH~2~O/PEEP 5 cmH~2~OChinaFullAdultNot reportedFigueroa-Casas 2010 \[[@CR39]\] (*n* = 122)ATC^b^/PEEP 5 cmH~2~O vs CPAP 5 cmH~2~OUSAFullAdult\>24 hoursMolina-Saldarriaga 2010 \[[@CR40]\] (*n* =50)CPAP^c^ vs T-pieceColombiaFullAdult\>48 hoursCekman 2011 \[[@CR41]\] (*n* = 40)CPAP [\<]{.ul} 5 cmH~2~O vs T-pieceTurkeyFullAdult\>48 hoursVats 2012 \[[@CR42]\] (*n* = 40)T-piece vs PS 7 cmH~2~OIndiaFullAdultNot reportedEl-beleidy 2013 \[[@CR43]\] (*n* = 36)ATC^b^/CPAP 5 cmH~2~O vs PS 6--10 cmH~2~O/CPAP 5 cmH~2~OEgyptFullPediatric\>24 hoursLourenco 2013 \[[@CR44]\] (*n* = 30)T-piece vs PS (not specified)BrazilFullAdultPerioperativeSherif 2013 \[[@CR45]\] (*n* = 100)PS (not specified) vs PS/ATCEgyptAbstractAdultNot reportedBilan 2015 \[[@CR46]\] (*n* = 51)CPAP vs T-pieceIranFullPediatricNot reportedChittawatanarat 2015 \[[@CR47]\] (*n* = 520)T-piece vs PS 7 cmH~2~O/PEEP [\<]{.ul} 5 cmH~2~OThailandAbstractAdult\>12 hoursTeixeira 2015 \[[@CR48]\] (*n* = 160)PS 7 cmH~2~O/PEEP 5 --8 cmH~2~O vs PAV+/PEEP 5 --8 cmH~2~O vs T-pieceBrazilFullAdult\>24 hours*PEEP* positive end-expiratory pressure, *IMV* intermittent mandatory ventilation, *CPAP* continuous positive airway pressure, *SVT* spontaneous ventilation trial, *ZEEP* zero end-expiratory pressure, *SIMV* synchronized intermittent mandatory ventilation, *PS* pressure support, *ATC* automatic tube compensation; *PAV*+ proportional assist ventilation with load adjustable gain factors^a^T-piece with CPAP 0 cmH~2~O^b^ATC with 100% compensation^c^CPAP set to 85% of intrinsic PEEP Table 2Summary of findings: PS vs T-piece SBTs on SBT and extubation successOutcomeIllustrative comparative risks^a^ (95% CI)Risk ratio (95% CI)Number of participants (trials)Quality of evidence (GRADE)Assumed risk, T-pieceCorresponding risk, pressure supportPS vs T-piece SBTs on SBT successStudy population1.00 (0.89--1.11)1901 (9 trials)⊕ ⊕ ⊕⊝ moderate^b^766 per 1000766 per 1000 (681--850)PS vs T-piece SBTs on extubation successStudy population1.06 (1.02--1.1)1904 (11 trials)⊕ ⊕ ⊕⊝ moderate^c^749 per 1000794^d^ per 1000 (764--824)*PS* pressure support, *CI* confidence interval, *SBT* spontaneous breathing trial, *GRADE* Grading of Recommendations Assessment, Development and Evaluation, *NNT* number needed to treat^a^The assumed risk is based on the median control group risk across studies. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). NNT is 1000/(794--749) = 22 (95% CI 13--67)^b^The Chittawatanarat \[[@CR47]\] trial skews data, increases heterogeneity, and changes summary estimate of effect. It also changes our interpretation of the findings^c^Methodologic concerns with the Colombo trial (quasi-randomized) \[[@CR34]\]; this trial carries 10% weight in the pooled extubation outcome meta-analysis^d^Corresponds to NNT of 794--749 = 45 or 1000/45 = 22 (95% CI 13--67) Fig. 2Forest plot comparing effect of SBT technique (PS vs T-piece) on SBT success. The pooled risk ratio with 95% confidence interval (*CI*) was calculated using a random effects model. Weight refers to the contribution of each study to the overall estimate of treatment effect. *PS* pressure support

Low-quality evidence from three trials (*n* = 247) suggests that patients were significantly more likely to pass an SBT with ATC + CPAP compared with CPAP alone (RR 1.12, 95% CI 1.04--1.22; *p* = 0.005, *I* ^2^ = 0%). Similarly, low-quality evidence from three trials (*n* = 276) showed that patients were significantly more likely to pass an SBT with ATC + CPAP compared with PS (RR 1.10, 95% CI 1.01--1.20; *p* = 0.02, *I* ^2^ = 0%) (Table [3](#Tab3){ref-type="table"}).Table 3Summary estimates of effect for comparisons of ATC vs other techniques on SBT successComparisonTrialsRisk ratio (95% CI)*p* value*I* ^2^ (%)ATC/CPAP vs CPAP3 (*n* = 247)1.12 (1.04--1.22)0.0050ATC/CPAP vs PS3 (*n* = 276)1.10 (1.01--1.20)0.020ATC vs T-piece2 (*n* = 157)1.03 (0.76--1.42)0.8381ATC/PS vs PS1 (*n* = 100)1.04 (0.94--1.15)0.40NA*ATC* automatic tube compensation, *CPAP* continuous positive airway pressure, *PS* pressure support, *CI* confidence interval, *I* ^2^ measure of heterogeneity, *SBT* spontaneous breathing trial

### Extubation success {#Sec12}

Seventeen T-piece, eight CPAP, eight ATC, and 14 PS trials compared one SBT technique with another and reported extubation success (Table [1](#Tab1){ref-type="table"}). Moderate-quality evidence supports that patients undergoing PS compared with T-piece SBTs were significantly more likely to be extubated successfully (RR 1.06, 95% CI 1.02--1.10; *p* = 0.007; 11 trials, *n* = 1904; *I* ^2^ = 0%) (Table [2](#Tab2){ref-type="table"}, Fig. [3](#Fig3){ref-type="fig"}, Additional file [4](#MOESM4){ref-type="media"}: Figure S3).Fig. 3Forest plot comparing effect of SBT technique (PS vs T-piece) on extubation success. The pooled risk ratio with 95% confidence interval (*CI*) was calculated using a random effects model. Weight refers to the contribution of each study to the overall estimate of treatment effect. *RR* risk ratio, *PS* pressure support

### Reintubation rate {#Sec13}

Fourteen T-piece, nine CPAP, seven ATC, and 13 PS trials comparing one SBT technique with another reported the reintubation rate and found no statistically significant differences between techniques (Table [1](#Tab1){ref-type="table"}, Additional file [5](#MOESM5){ref-type="media"}: Figure S4).

### Secondary outcomes {#Sec14}

There was no effect of one SBT technique vs another on ICU mortality (seven T-piece, three CPAP, and five PS trials), hospital mortality (four T-piece and four PS trials), or the most protracted mortality measure (10 T-piece, four CPAP, and seven PS trials).

No trial reported time to extubation or time to successful extubation. Meta-analysis of three trials comparing ATC + CPAP with CPAP alone found no difference in NIV use after extubation (RR 0.53, 95% CI 0.27--1.06; *p* = 0.07, *I* ^2^ = 0%).

### Sensitivity, subgroup, and post-hoc analyses {#Sec15}

Exclusion of a single quasi-randomized trial comparing PS vs T-piece SBTs \[[@CR34]\] did not change the significant increase in extubation success favoring PS SBTs (RR 1.05, 95% CI 1.01--1.10; *p* = 0.02, *I* ^2^ = 0%).

Meta-analyses of PS vs T-piece SBTs showed benefit in seven nonperioperative trials (*n* = 1273; RR 1.07, 95% CI 1.01--1.13; *p* = 0.02, *I* ^2^ = 94%) (high-quality evidence) compared with two perioperative trials (*n* = 548; RR 0.86, 95% CI 0.61--1.22; *p* = 0.41, *I* ^2^ = 0%) (low-quality evidence); however, an interaction test showed no difference between these summary estimates (*p* = 0.23) (Additional file [6](#MOESM6){ref-type="media"}: Table S1, Additional file [7](#MOESM7){ref-type="media"}: Figure S5). Subgroup analyses based on duration of ventilation among nonperioperative trials was not feasible given similar reported durations of ventilation. Subgroup analyses comparing more vs less inspiratory support and type of lung disease were not significant for commonly reported comparisons of alternative techniques. A sensitivity analysis was not possible due to the absence of blinded outcomes assessment across trials. Inspection of a funnel plot for 11 trials comparing PS with T-piece SBTs on extubation success did not suggest publication bias.

We conducted a post-hoc analysis that excluded a single, surgical trial \[[@CR47]\] which enrolled surgical patients, was published in abstract form only, and had internally inconsistent results (i.e., lower initial SBT success rate but higher extubation success rate for PS vs T-piece SBTs). When this trial was excluded, meta-analyses showed that more patients passed an initial PS (vs T-piece) SBT (RR 1.06, 95% CI 1.01--1.12; *p* = 0.03) without heterogeneity (*I* ^2^ = 0%) and were similarly extubated successfully (RR 1.06, 95% CI 1.01--1.12; *p* = 0.03, *I* ^2^ = 0%). Excluding each of the other RCTs in a full leave-one-study-out analysis did not result in significant changes to the pooled effect estimate for SBT success (pooled RR range, 0.98--1.01) or heterogeneity (*I* ^2^ range, 77--80%) suggesting that only a single trial \[[@CR47]\] was an outlier for this outcome. In a similar analysis for extubation success, the pooled RR ranged from 1.05 to 1.07 and remained statistically significant with no heterogeneity (*I* ^2^ = 0%) regardless of which RCT was removed, suggesting that no trial was an outlier or disproportionately influenced the extubation success summary estimate.

Discussion {#Sec16}
==========

We identified 31 trials of overall moderate quality reporting on 3541 patients. Moderate-quality evidence supported that SBT success rates were similar with PS and T-piece, with substantial heterogeneity. However, post-hoc exclusion of an unpublished trial \[[@CR47]\] with inconsistent results eliminated the heterogeneity and showed that SBT success was 6% more likely with PS SBTs. Meta-analysis also showed a 6% higher probability of successful extubation following PS (vs T-piece) SBTs, with no heterogeneity, irrespective of this trial's inclusion \[[@CR47]\]. Although a 6% relative improvement in probability of successful extubation may appear small, it corresponds to a clinically important number needed to treat of 22 (95% CI 13--67) when the baseline risk of extubation success is 75% (Table [2](#Tab2){ref-type="table"}). Low-quality evidence from three trials indicated that patients were 12% more likely to pass an SBT with ATC + CPAP/PEEP compared with CPAP and were 10% more likely to pass an SBT with ATC + CPAP/PEEP compared with PS, although extubation success rates were similar. We found no differences between alternative SBT techniques on reintubation rate or mortality, although CIs were wide. Subgroup analysis suggested beneficial effects of PS vs T-piece SBTs on SBT success in seven nonperioperative trials (high-quality evidence) compared with two perioperative trials (low-quality evidence), but the RRs were not statistically dissimilar.

Most trials directly compared T-piece with PS SBTs (13 trials) and T-piece with CPAP SBTs (nine trials). Very few trials assessed alternative SBT techniques in children. Most trials (*n* = 22) were conducted in patients who were nonperioperative and for whom extubation decisions are considered more challenging. In pooling outcomes, we noted that five of six cardiac surgery trials reported a 100% SBT success rate in both arms and three surgical trials reported a 100% extubation success rate in both arms. These findings suggest that the most important question in postoperative patients with a high pretest probability of SBT and extubation success may be whether an SBT is necessary and that questions regarding the best SBT technique to use may be most relevant to patients at indeterminate or low pretest probability of success.

Our systematic review differs from two previous reviews by directly comparing SBT techniques and excluding trials evaluating SBT techniques as one component of a weaning strategy \[[@CR7], [@CR51]\]. Moreover, we hand-searched conference proceedings spanning 26 years, where feasible, and included pediatric trials. Compared with the Cochrane review of nine trials \[[@CR7]\], we included nine additional trials (one pediatric trial \[[@CR28]\], four adult trials \[[@CR34], [@CR38], [@CR42], [@CR44]\], two abstracts \[[@CR27], [@CR47]\], and two three-arm trials \[[@CR30], [@CR48]\]) comparing T-piece and PS SBTs and excluded four weaning trials \[[@CR52]--[@CR55]\]. Contrary to their findings, we found that patients were only more likely to pass a PS (vs T-piece) SBT after exclusion of a single outlier trial \[[@CR47]\] but were significantly more likely to be extubated successfully. This finding remained significant after exclusion of a single pediatric trial \[[@CR28]\]. Compared with a recent meta-analysis of 12 trials \[[@CR51]\], we included five additional trials (one pediatric trial \[[@CR28]\], three adult trials \[[@CR34], [@CR42], [@CR48]\] including a three-arm trial \[[@CR48]\], and an abstract \[[@CR27]\]) and excluded four trials involving weaning or tracheostomized patients \[[@CR52], [@CR53], [@CR55], [@CR56]\]. Similar to their review, we found that the SBT technique did not influence rates of weaning success, mortality, or reintubation.

Considerable debate exists regarding the SBT technique that best simulates patient's WOB after extubation. An SBT approximates the patient's ability to breathe spontaneously, but it is an imperfect test because it cannot take into consideration factors (e.g., upper airway resistance, respiratory muscle fatigue, cardiac decompensation, accumulation of secretions) that may occur after extubation. There are several physiological reasons for the clinical observation that PS SBTs may lead to more successful initial SBTs and extubations. By overcoming a portion of the pressure gradient across the endotracheal tube, low levels of PS or CPAP provide minimal but potentially important support during an SBT. A systematic review of the effect of different SBTs on physiological outcomes found that metrics of patient effort (WOB (n = 142) and pressure--time product (PTP) (*n* = 129)) were significantly higher during T-piece vs PS SBTs, with significant heterogeneity (*I* ^2^ ≥ 75%). These metrics during T-piece SBTs were also more comparable with the postextubation period compared with PS SBTs, although sample sizes were small (*n* = 77 for WOB; *n* = 52 for PTP) and heterogeneity was moderate (*I* ^2^ = 67% and 62%, respectively) \[[@CR57]\]. Most patients, especially those with high pretest probability of success who represent the majority of patients submitted to SBTs \[[@CR6], [@CR58]\], can be extubated easily after an initial SBT \[[@CR58]\]. However, T-piece SBTs may be appropriate in selected patients (e.g. severe left ventricular dysfunction, neuromuscular weakness, difficult airway) when clinicians are uncertain regarding their ability to breathe on their own and when they prioritize a low false positive rate for passing an SBT and being extubated successfully due to the risks associated with extubation failure \[[@CR59]\]. Conversely, when T-piece (vs PS) SBTs are used in patients with a high likelihood of extubation success, they may induce a high false negative rate. Compared with T-piece SBTs, our review may suggest that PS SBTs facilitate extubation decision-making. Even if PS SBTs underestimate postextubation WOB, their successful completion may offset clinician reluctance to extubate, resulting in more timely and successful extubation without increased reintubation \[[@CR60], [@CR61]\]. This may be the primary reason why PS SBTs result in both higher SBT and extubation success rates; otherwise one might expect a test that underestimates postextubation WOB to yield a higher SBT success rate followed by a higher reintubation rate. However, reintubation may be related not only to SBT technique and outcome but also to extubation readiness and new and concomitant illnesses. Furthermore, compared with T-piece SBTs, PS SBTs do not require that clinicians assemble a T-piece circuit or disconnect the patient from the ventilator or its alarms, and permit application of PEEP that reduces the potential for loss of lung aeration immediately prior to extubation. Although passing an initial SBT is an important outcome, patients may undergo serial SBTs before extubation, and stakeholders prioritize being extubated successfully \[[@CR62]\].

Several additional findings warrant commentary. First, few trials reported use of daily screening or the criteria used to identify SBT candidates and assess extubation readiness. Second, we noted wide variation in initial SBT success rates across trials comparing PS (range, 54.3--100.0%) with T-piece (range, 53.0--100.0%) SBTs and comparing ATC + CPAP (range, 64.7--96.7%) with PS (range, 52.6--86.0%) SBTs, and, similarly, broad variation in extubation success rates comparing PS (range, 60.0--100.0%) with T-piece (range, 50.0--100.0%) SBTs. Conversely, we noted higher SBT success rates in three trials comparing ATC and CPAP (range, 93.3--96.6%) with CPAP alone (range, 80.0--86.7%). While SBT and extubation summary estimates differed quantitatively across comparisons, qualitatively the direction of effect favored SBTs conducted with inspiratory support. Third, only eight trials \[[@CR25], [@CR28]--[@CR30], [@CR34], [@CR37], [@CR38], [@CR43]\] specified addition of CPAP (or PEEP) to PS during SBTs. Fourth, trials were predominantly of moderate quality. Finally, although we included pediatric trials, we only identified three such trials. Because each pediatric trial compared different techniques (T-piece vs PS + PEEP \[[@CR28]\], ATC/CPAP vs PS/CPAP \[[@CR43]\], and CPAP vs T-piece \[[@CR46]\]) our ability to compare outcomes in children vs adults was limited. Results for the pediatric trials were not different from the pooled results of the adult trials for any of the outcomes (interaction *p* values all nonsignificant; results not shown).

Our review is the first to directly compare alternative SBT techniques and was strengthened by an extensive search, duplicate citation screening and data abstraction, use of random effects models to pool data, and conduct of prespecified subgroup analyses. Our review also has limitations. Included trials were predominantly of moderate quality with no trial conducting blinded outcomes assessment and summary estimates were limited by variable outcomes reporting and unclear prospective follow-up. Statistical noise could be minimized if SBT techniques were applied serially until extubation and if extubation was restricted to patients who passed an SBT. Only five trials, all comparing PS with T-piece SBTs, reported conducting SBTs daily \[[@CR31], [@CR35]\], daily up to 3 days \[[@CR29], [@CR48]\], or for an undisclosed time \[[@CR38]\]. Despite subgroup analyses, we cannot fully elucidate the impact of pretest probability of SBT or extubation success on the effect of SBT as patients at intermediate or high likelihood of SBT and extubation success dominated the analysis. The implications of our findings for patients with low pretest probability remain uncertain. Finally, our ability to assess the impact of other factors (e.g., pre-randomization duration of ventilation, type of ICU, presence of dedicated respiratory care personnel) in subgroup analyses was constrained by small numbers of trials and variable and limited reporting. Furthermore, SBT durations were variable. Two RCTs randomizing patients to 30 vs 120 minutes duration of T-piece \[[@CR63]\] or PS \[[@CR64]\] SBTs found nonsignificant differences in SBT and extubation success rates. In addition, a very recent multicenter RCT published only in abstract form \[[@CR65]\] suggests that reventilating patients for 1 hour after a successful SBT may increase successful extubation rates.

Conclusion {#Sec17}
==========

Patients undergoing PS vs T-piece SBTs appear to be 6% (95% CI 2--10%,) more likely to be extubated successfully, and, if the results of an outlier trial are excluded, are 6% (95% CI 1--12%) more likely to pass an SBT. PS SBTs were not associated with an increased risk of reintubation or mortality, but CIs were wide.
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ATC

:   Automatic tube compensation

CI

:   Confidence interval

CPAP

:   Continuous positive airway pressure

GRADE

:   Grading of Recommendations Assessment, Development and Evaluation

ICU

:   Intensive care unit

LOS

:   Length of stay

MD

:   Mean difference

NIV

:   Noninvasive ventilation

PEEP

:   Positive end-expiratory pressure

PS

:   Pressure support

RCT

:   Randomized controlled trial

RoB

:   Risk of bias

RR

:   Risk ratio

SBT

:   Spontaneous breathing trial

VAP

:   Ventilator-associated pneumonia

WOB

:   Work of breathing
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